nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—Vandetanib—AXL—refractive error	0.0885	1	CrCbGaD
Erlotinib—EGFR—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00116	0.00127	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—CACNA1D—refractive error	0.00114	0.00125	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—PDGFRA—refractive error	0.00114	0.00125	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RDH5—refractive error	0.00112	0.00123	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—CYP26A1—refractive error	0.00112	0.00123	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00111	0.00122	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—EBP—refractive error	0.00111	0.00122	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—WNT10A—refractive error	0.00111	0.00122	CbGpPWpGaD
Erlotinib—CYP2D6—Metapathway biotransformation—CYP26A1—refractive error	0.0011	0.00121	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—PDGFRA—refractive error	0.00109	0.0012	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—PDGFRA—refractive error	0.00108	0.00119	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—VIPR2—refractive error	0.00108	0.00119	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—PDGFRA—refractive error	0.00108	0.00118	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—PDGFRA—refractive error	0.00107	0.00118	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AXL—refractive error	0.00106	0.00117	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—refractive error	0.00106	0.00116	CbGpPWpGaD
Erlotinib—MAP2K5—Insulin Signaling—PTEN—refractive error	0.00105	0.00115	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—COL9A1—refractive error	0.00105	0.00115	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CER1—refractive error	0.00104	0.00114	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RNF111—refractive error	0.00104	0.00114	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TJP2—refractive error	0.00104	0.00114	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—COL9A1—refractive error	0.00104	0.00114	CbGpPWpGaD
Erlotinib—MAP2K5—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00104	0.00114	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—EBP—refractive error	0.00104	0.00114	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—PDGFRA—refractive error	0.00101	0.00111	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—PDGFRA—refractive error	0.00101	0.00111	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00101	0.00111	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—PDGFRA—refractive error	0.001	0.0011	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GREM2—refractive error	0.000993	0.00109	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.000992	0.00109	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CTSC—refractive error	0.000988	0.00108	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—PDGFRA—refractive error	0.000988	0.00108	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—PDGFRA—refractive error	0.000972	0.00107	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VANGL2—refractive error	0.000972	0.00107	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.000968	0.00106	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.000968	0.00106	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00096	0.00105	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—PDGFRA—refractive error	0.000954	0.00105	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00095	0.00104	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—CYP26A1—refractive error	0.000947	0.00104	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—EBP—refractive error	0.000942	0.00103	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—PDGFRA—refractive error	0.000935	0.00103	CbGpPWpGaD
Erlotinib—CYP1A2—Metapathway biotransformation—CYP26A1—refractive error	0.000934	0.00102	CbGpPWpGaD
Erlotinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.000924	0.00101	CbGpPWpGaD
Erlotinib—EGFR—Disease—DSE—refractive error	0.000914	0.001	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—EBP—refractive error	0.000913	0.001	CbGpPWpGaD
Erlotinib—MAP2K5—Focal Adhesion—PTEN—refractive error	0.000913	0.001	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—WNT10A—refractive error	0.000903	0.000991	CbGpPWpGaD
Erlotinib—EGFR—Androgen receptor signaling pathway—PTEN—refractive error	0.000899	0.000986	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.000894	0.000981	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—PTEN—refractive error	0.000894	0.000981	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.000887	0.000973	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.000887	0.000973	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.000882	0.000968	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.000882	0.000968	CbGpPWpGaD
Erlotinib—JAK3—Immune System—PML—refractive error	0.000878	0.000963	CbGpPWpGaD
Erlotinib—EGFR—Disease—RDH5—refractive error	0.000859	0.000942	CbGpPWpGaD
Erlotinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000856	0.000939	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CER1—refractive error	0.000849	0.000932	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TJP2—refractive error	0.000849	0.000932	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RNF111—refractive error	0.000849	0.000932	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CHN1—refractive error	0.000844	0.000926	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—DSE—refractive error	0.000842	0.000924	CbGpPWpGaD
Erlotinib—EGFR—PI-3K cascade—PTEN—refractive error	0.000832	0.000913	CbGpPWpGaD
Erlotinib—ABL1—Immune System—RNF111—refractive error	0.000825	0.000905	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—WNT10A—refractive error	0.000821	0.0009	CbGpPWpGaD
Erlotinib—EGFR—Disease—PCCA—refractive error	0.000814	0.000893	CbGpPWpGaD
Erlotinib—EGFR—PI3K/AKT activation—PTEN—refractive error	0.000812	0.000891	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—PAX6—refractive error	0.000811	0.00089	CbGpPWpGaD
Erlotinib—EGFR—GAB1 signalosome—PTEN—refractive error	0.000806	0.000884	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.000806	0.000884	CbGpPWpGaD
Erlotinib—ABL1—PDGFR-beta signaling pathway—PTEN—refractive error	0.000801	0.000879	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—COL9A1—refractive error	0.00079	0.000866	CbGpPWpGaD
Erlotinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.000787	0.000864	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—DSE—refractive error	0.000785	0.000861	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—OR2M7—refractive error	0.000752	0.000825	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PLA2G16—refractive error	0.00075	0.000823	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PCCA—refractive error	0.00075	0.000823	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—TUBB3—refractive error	0.000745	0.000817	CbGpPWpGaD
Erlotinib—EGFR—Disease—IPO5—refractive error	0.000745	0.000817	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.000731	0.000802	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.000721	0.000791	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—BMP2—refractive error	0.000718	0.000787	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—DSE—refractive error	0.000714	0.000784	CbGpPWpGaD
Erlotinib—EGFR—Immune System—RNF111—refractive error	0.000705	0.000773	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CTSC—refractive error	0.000702	0.00077	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PLA2G16—refractive error	0.0007	0.000768	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PCCA—refractive error	0.0007	0.000768	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—PAX6—refractive error	0.000693	0.00076	CbGpPWpGaD
Erlotinib—EGFR—Disease—WNT10A—refractive error	0.000692	0.00076	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—PTEN—refractive error	0.000689	0.000756	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—PDGFRA—refractive error	0.000688	0.000755	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—EBP—refractive error	0.000675	0.000741	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.000661	0.000725	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—PTEN—refractive error	0.000658	0.000722	CbGpPWpGaD
Erlotinib—ABL1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000651	0.000715	CbGpPWpGaD
Erlotinib—EGFR—Disease—RNF111—refractive error	0.000651	0.000714	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—COL9A1—refractive error	0.000644	0.000706	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VIPR2—refractive error	0.00064	0.000702	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PDGFRA—refractive error	0.00064	0.000702	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—EBP—refractive error	0.000638	0.0007	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PCCA—refractive error	0.000637	0.000698	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PLA2G16—refractive error	0.000637	0.000698	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—PTEN—refractive error	0.000625	0.000686	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—PTEN—refractive error	0.000622	0.000682	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.000617	0.000677	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.000617	0.000677	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RDH5—refractive error	0.000601	0.00066	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CTSC—refractive error	0.000599	0.000658	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling of activated FGFR—PTEN—refractive error	0.000595	0.000653	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—PTEN—refractive error	0.000589	0.000646	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—PTEN—refractive error	0.000586	0.000643	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—EBP—refractive error	0.000585	0.000642	CbGpPWpGaD
Erlotinib—ALB—Metabolism—EBP—refractive error	0.000582	0.000638	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000571	0.000626	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AXL—refractive error	0.00057	0.000626	CbGpPWpGaD
Erlotinib—EGFR—Disease—LUM—refractive error	0.000564	0.000619	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—PTEN—refractive error	0.000559	0.000614	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—PTEN—refractive error	0.000557	0.000611	CbGpPWpGaD
Erlotinib—EGFR—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000557	0.000611	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—PTEN—refractive error	0.000554	0.000608	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—PTEN—refractive error	0.000551	0.000605	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.000543	0.000596	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—BMP2—refractive error	0.000541	0.000594	CbGpPWpGaD
Erlotinib—JAK3—Immune System—PDGFRA—refractive error	0.000522	0.000573	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VANGL2—refractive error	0.000521	0.000572	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—LUM—refractive error	0.00052	0.000571	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—PTEN—refractive error	0.000518	0.000569	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000518	0.000569	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—PTEN—refractive error	0.000518	0.000569	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—PTEN—refractive error	0.000514	0.000564	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DSE—refractive error	0.000512	0.000561	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—EBP—refractive error	0.00051	0.000559	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—PTEN—refractive error	0.000509	0.000559	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—PTEN—refractive error	0.000507	0.000556	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CACNA1D—refractive error	0.000501	0.000549	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—PTEN—refractive error	0.00049	0.000537	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000488	0.000535	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—LUM—refractive error	0.000485	0.000532	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—WNT10A—refractive error	0.000485	0.000532	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DSE—refractive error	0.000483	0.00053	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—EBP—refractive error	0.00048	0.000527	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—PTEN—refractive error	0.00048	0.000526	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00048	0.000526	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CACNA1D—refractive error	0.000467	0.000512	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—TUBB3—refractive error	0.00046	0.000504	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000459	0.000504	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—PDGFRA—refractive error	0.000459	0.000504	CbGpPWpGaD
Erlotinib—EGFR—Disease—RPS27—refractive error	0.000456	0.000501	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PCCA—refractive error	0.000456	0.0005	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PLA2G16—refractive error	0.000456	0.0005	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RNF111—refractive error	0.000456	0.0005	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TJP2—refractive error	0.000456	0.0005	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CER1—refractive error	0.000456	0.0005	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PML—refractive error	0.000449	0.000493	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—PDGFRA—refractive error	0.000448	0.000491	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DSE—refractive error	0.000443	0.000486	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CYP26A1—refractive error	0.000442	0.000485	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—LUM—refractive error	0.000441	0.000484	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—BMP2—refractive error	0.000441	0.000484	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DSE—refractive error	0.000441	0.000484	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PLA2G16—refractive error	0.000431	0.000473	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PCCA—refractive error	0.000431	0.000473	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CACNA1D—refractive error	0.000425	0.000466	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CYP26A1—refractive error	0.000412	0.000452	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—EBP—refractive error	0.000407	0.000446	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	0.000403	0.000442	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PLA2G16—refractive error	0.000395	0.000433	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PCCA—refractive error	0.000395	0.000433	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PCCA—refractive error	0.000393	0.000431	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PLA2G16—refractive error	0.000393	0.000431	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—PDGFRA—refractive error	0.000392	0.00043	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DSE—refractive error	0.000386	0.000424	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PML—refractive error	0.000384	0.000421	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—PDGFRA—refractive error	0.000377	0.000413	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CYP26A1—refractive error	0.000375	0.000412	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DSE—refractive error	0.000364	0.000399	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—PTEN—refractive error	0.000353	0.000387	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—COL9A1—refractive error	0.000345	0.000379	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PLA2G16—refractive error	0.000344	0.000378	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PCCA—refractive error	0.000344	0.000378	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—PDGFRA—refractive error	0.000338	0.000371	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PTEN—refractive error	0.000328	0.00036	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PLA2G16—refractive error	0.000324	0.000356	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PCCA—refractive error	0.000324	0.000356	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LUM—refractive error	0.000316	0.000347	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—EBP—refractive error	0.000314	0.000344	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DSE—refractive error	0.000308	0.000338	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CACNA1D—refractive error	0.000304	0.000334	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LUM—refractive error	0.000299	0.000328	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CACNA1D—refractive error	0.000288	0.000315	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PDGFRA—refractive error	0.000275	0.000302	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PLA2G16—refractive error	0.000275	0.000301	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PCCA—refractive error	0.000275	0.000301	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LUM—refractive error	0.000274	0.0003	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LUM—refractive error	0.000272	0.000299	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP26A1—refractive error	0.000269	0.000295	CbGpPWpGaD
Erlotinib—JAK3—Immune System—PTEN—refractive error	0.000268	0.000294	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PDGFRA—refractive error	0.000267	0.000293	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CACNA1D—refractive error	0.000264	0.000289	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CACNA1D—refractive error	0.000262	0.000288	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP26A1—refractive error	0.000254	0.000279	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000246	0.00027	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LUM—refractive error	0.000239	0.000262	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DSE—refractive error	0.000238	0.000261	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—BMP2—refractive error	0.000237	0.00026	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—PTEN—refractive error	0.000236	0.000259	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP26A1—refractive error	0.000233	0.000255	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP26A1—refractive error	0.000232	0.000254	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—PTEN—refractive error	0.00023	0.000252	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNA1D—refractive error	0.00023	0.000252	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PDGFRA—refractive error	0.000229	0.000251	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LUM—refractive error	0.000225	0.000247	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNA1D—refractive error	0.000216	0.000237	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PCCA—refractive error	0.000212	0.000233	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLA2G16—refractive error	0.000212	0.000233	CbGpPWpGaD
Erlotinib—EGFR—Disease—PDGFRA—refractive error	0.000211	0.000231	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000209	0.000229	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP26A1—refractive error	0.000203	0.000223	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—PTEN—refractive error	0.000201	0.000221	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—PTEN—refractive error	0.000193	0.000212	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP26A1—refractive error	0.000191	0.00021	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LUM—refractive error	0.00019	0.000209	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNA1D—refractive error	0.000183	0.000201	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—PTEN—refractive error	0.000173	0.00019	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP26A1—refractive error	0.000162	0.000178	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PDGFRA—refractive error	0.000148	0.000162	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LUM—refractive error	0.000147	0.000161	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNA1D—refractive error	0.000141	0.000155	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PTEN—refractive error	0.000141	0.000155	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PTEN—refractive error	0.000137	0.000151	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000129	0.000141	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP26A1—refractive error	0.000125	0.000137	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000118	0.000129	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000117	0.000129	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PTEN—refractive error	0.000117	0.000129	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTEN—refractive error	0.000108	0.000119	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTEN—refractive error	9.98e-05	0.00011	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTEN—refractive error	9.31e-05	0.000102	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTEN—refractive error	8.47e-05	9.29e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—refractive error	8.21e-05	9.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTEN—refractive error	7.59e-05	8.32e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTEN—refractive error	6.07e-05	6.66e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTEN—refractive error	5.73e-05	6.29e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTEN—refractive error	5.26e-05	5.77e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTEN—refractive error	5.23e-05	5.73e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTEN—refractive error	4.58e-05	5.02e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTEN—refractive error	4.32e-05	4.73e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTEN—refractive error	3.66e-05	4.01e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTEN—refractive error	2.82e-05	3.1e-05	CbGpPWpGaD
